These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 24448760

  • 1. Novel strategies for toxicological risk assessments.
    Roy A, Akbarsha MA.
    ALTEX; 2014; 31(1):91-3. PubMed ID: 24448760
    [No Abstract] [Full Text] [Related]

  • 2. Evidence-Based Toxicology Collaboration (EBTC). Editorial.
    von Aulock S.
    ALTEX; 2013; 30(1):1. PubMed ID: 23451363
    [No Abstract] [Full Text] [Related]

  • 3. Novel technologies and an overall strategy to allow hazard assessment and risk prediction of chemicals, cosmetics, and drugs with animal-free methods.
    Leist M, Lidbury BA, Yang C, Hayden PJ, Kelm JM, Ringeissen S, Detroyer A, Meunier JR, Rathman JF, Jackson GR, Stolper G, Hasiwa N.
    ALTEX; 2012; 29(4):373-88. PubMed ID: 23138508
    [Abstract] [Full Text] [Related]

  • 4. Alternatives to the use of animals in safety testing as required by the EU-Cosmetics Directive 2009.
    Vogel R.
    ALTEX; 2009; 26(3):223-6. PubMed ID: 19907908
    [Abstract] [Full Text] [Related]

  • 5. Toxicity testing: the need for new maps for the future.
    Balls M.
    Altern Lab Anim; 2011 Oct; 39(5):417-8. PubMed ID: 22103936
    [No Abstract] [Full Text] [Related]

  • 6. The use and interpretation of in vitro data in regulatory toxicology: cosmetics, toiletries and household products.
    Indans I.
    Toxicol Lett; 2002 Feb 28; 127(1-3):177-82. PubMed ID: 12052656
    [Abstract] [Full Text] [Related]

  • 7. The integrated project ReProTect: a novel approach in reproductive toxicity hazard assessment.
    Hareng L, Pellizzer C, Bremer S, Schwarz M, Hartung T.
    Reprod Toxicol; 2005 Feb 28; 20(3):441-52. PubMed ID: 15899576
    [Abstract] [Full Text] [Related]

  • 8. Introduction to the EU REACH legislation.
    Grindon C, Combes R.
    Altern Lab Anim; 2006 Mar 28; 34 Suppl 1():5-10. PubMed ID: 16555955
    [Abstract] [Full Text] [Related]

  • 9. Integrated Approaches to Testing and Assessment.
    Casati S.
    Basic Clin Pharmacol Toxicol; 2018 Sep 28; 123 Suppl 5():51-55. PubMed ID: 29604238
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Immunotoxicity: hazard identification and risk assessment.
    Luster MI, Kimber I.
    Hum Exp Toxicol; 1996 Dec 28; 15(12):947-8. PubMed ID: 8981097
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Toxicology is IN: in silico, in vitro, integrated testing strategy.
    Caloni F, Benfenati E, Sambuy Y.
    ALTEX; 2016 Dec 28; 33(2):187-8. PubMed ID: 27032091
    [No Abstract] [Full Text] [Related]

  • 15. Reply to: Bayesian network integrated testing strategy and beyond.
    Jaworska J.
    ALTEX; 2013 Dec 28; 30(3):391. PubMed ID: 23861082
    [No Abstract] [Full Text] [Related]

  • 16. Predictive toxicology today: the transition from biological knowledge to practicable models.
    Benigni R.
    Expert Opin Drug Metab Toxicol; 2016 Sep 28; 12(9):989-92. PubMed ID: 27351633
    [No Abstract] [Full Text] [Related]

  • 17. Integrated testing strategies for use in the EU REACH system.
    Grindon C, Combes R, Cronin MT, Roberts DW, Garrod JF.
    Altern Lab Anim; 2006 Aug 28; 34(4):407-27. PubMed ID: 16945008
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. REACH testing requirements must not be driven by reproductive toxicity testing.
    Spielmann H, Vogel R.
    Altern Lab Anim; 2006 Aug 28; 34(4):365-6. PubMed ID: 16945004
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.